Medexus Pharmaceuticals Hits Day High with 13.59% Surge in Stock Price

Medexus Pharmaceuticals, Inc. has experienced a significant surge in its stock performance, gaining 13.59% on June 30, 2026. The stock reached an intraday high of CAD 5.10, reflecting a strong day of trading for the small-cap company in the Pharmaceuticals and Biotechnology sector. Over the past week, Medexus has shown impressive growth, with a 25.93% increase, outpacing the S&P/TSX 60, which saw a slight decline of 0.26%. The company's one-month performance stands at 31.44%, while its year-to-date performance has soared to 75.26%, significantly higher than the S&P/TSX 60's 10.23%. Despite these short-term gains, Medexus has faced challenges, reporting negative results for the last four consecutive quarters. The company's net profit for the latest quarter fell to CAD 0.26 million, a decline of 85.06%. Additionally, its return on equity remains negative at -1.22%. While the stock has shown notable activity today, it is essential to consider the broader context of its financial performance and market position.